![Sylke Hassel](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Sylke Hassel
Amministratore Delegato presso PharmaZell GmbH
Profilo
Sylke Hassel is currently the Chief Executive Officer at PharmaZell GmbH, Novasep Holding SAS, Zellbios GmbH, and Zellbios GmbH.
Previously, Ms. Hassel served as the Chief Executive Officer & Managing Director at Axplora Group GmbH.
Posizioni attive di Sylke Hassel
Società | Posizione | Inizio |
---|---|---|
PharmaZell GmbH
![]() PharmaZell GmbH BiotechnologyHealth Technology PharmaZell GmbH engages in the development and provision of pharmaceutical active ingredients. It also offers services for formulation development and compiles required regulatory documents for both the originator and generic pharmaceutical industry. Its products include manufactured amino acids and controlled substances. The company was founded in 1946 and is headquartered in Raubling, Germany. | Amministratore Delegato | 01/08/2021 |
Novasep Holding SAS
![]() Novasep Holding SAS Chemicals: Major DiversifiedProcess Industries Novasep Holding SAS provides manufacturing solutions for the life science industries. Its products include agrochemicals fine chemicals and food ingredients. The company was founded by Roger-Marc Nicoud in 1995 and is headquartered in Lyon, France. | Amministratore Delegato | - |
Zellbios GmbH
![]() Zellbios GmbH Pharmaceuticals: MajorHealth Technology Part of PharmaZell GmbH, Zellbios GmbH is a German company that specializes in manufacturing cdmo solutions, supplying specialty api products, and producing anticancer drugs. Zellbios is based in Raubling, DE, and Sylke Hassel has been the CEO of the company since 2022. The company offers a wide range of reliable services for small molecule apis and biopharmaceuticals to innovators. Zellbios also supports innovative agrochemical companies with their apis for fungicides, insecticides, and herbicides in a safe and sustainable way. The company provides cdmo services for highly potent apis and cytotoxics and is an expert in pre-formulated nitroglycerin production. | Amministratore Delegato | 01/10/2022 |
Zellbios GmbH
![]() Zellbios GmbH Pharmaceuticals: MajorHealth Technology Part of PharmaZell GmbH, Zellbios GmbH is a German company that specializes in manufacturing cdmo solutions, supplying specialty api products, and producing anticancer drugs. Zellbios is based in Raubling, DE, and Sylke Hassel has been the CEO of the company since 2022. The company offers a wide range of reliable services for small molecule apis and biopharmaceuticals to innovators. Zellbios also supports innovative agrochemical companies with their apis for fungicides, insecticides, and herbicides in a safe and sustainable way. The company provides cdmo services for highly potent apis and cytotoxics and is an expert in pre-formulated nitroglycerin production. | Amministratore Delegato | 10/10/2023 |
Precedenti posizioni note di Sylke Hassel
Società | Posizione | Fine |
---|---|---|
Axplora
![]() Axplora Pharmaceuticals: OtherHealth Technology Axplora is a German company that focuses on delivering sustainable and technologically advanced API products and services. The private company is based in Raubling, Germany. The company's goal is to benefit people, patients, and the planet. The CEO of the company is Sylke Hassel. | Amministratore Delegato | 12/04/2024 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 4 |
---|---|
PharmaZell GmbH
![]() PharmaZell GmbH BiotechnologyHealth Technology PharmaZell GmbH engages in the development and provision of pharmaceutical active ingredients. It also offers services for formulation development and compiles required regulatory documents for both the originator and generic pharmaceutical industry. Its products include manufactured amino acids and controlled substances. The company was founded in 1946 and is headquartered in Raubling, Germany. | Health Technology |
Novasep Holding SAS
![]() Novasep Holding SAS Chemicals: Major DiversifiedProcess Industries Novasep Holding SAS provides manufacturing solutions for the life science industries. Its products include agrochemicals fine chemicals and food ingredients. The company was founded by Roger-Marc Nicoud in 1995 and is headquartered in Lyon, France. | Process Industries |
Zellbios GmbH
![]() Zellbios GmbH Pharmaceuticals: MajorHealth Technology Part of PharmaZell GmbH, Zellbios GmbH is a German company that specializes in manufacturing cdmo solutions, supplying specialty api products, and producing anticancer drugs. Zellbios is based in Raubling, DE, and Sylke Hassel has been the CEO of the company since 2022. The company offers a wide range of reliable services for small molecule apis and biopharmaceuticals to innovators. Zellbios also supports innovative agrochemical companies with their apis for fungicides, insecticides, and herbicides in a safe and sustainable way. The company provides cdmo services for highly potent apis and cytotoxics and is an expert in pre-formulated nitroglycerin production. | Health Technology |
Axplora
![]() Axplora Pharmaceuticals: OtherHealth Technology Axplora is a German company that focuses on delivering sustainable and technologically advanced API products and services. The private company is based in Raubling, Germany. The company's goal is to benefit people, patients, and the planet. The CEO of the company is Sylke Hassel. | Health Technology |
- Borsa valori
- Insiders
- Sylke Hassel